Home » Topics » Regulatory » NMPA

NMPA
RSS

CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026

April 16, 2018

No Comments

Chinese authorities approve clinical trials of ZKAB-001

Jan. 30, 2018

No Comments

China FDA accepts IND for Ascentage's IAP inhibitor

Jan. 9, 2018

No Comments

CFDA designates lenvatinib for priority review and approval for HCC

Dec. 28, 2017

No Comments

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Dec. 28, 2017

No Comments

Ebola vaccine approved in China

Oct. 26, 2017

No Comments

Fosun Pharma reports Chinese IND application for FCN-437c

July 19, 2017

No Comments

CStone cleared to begin clinical trials of CS-1001 in China

July 18, 2017

No Comments

China FDA accepts fruquintinib NDA for advanced colorectal cancer

June 12, 2017

No Comments

Tagrisso approved in China for NSCLC

March 27, 2017

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

NMPA
RSS

CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026

Chinese authorities approve clinical trials of ZKAB-001

China FDA accepts IND for Ascentage's IAP inhibitor

CFDA designates lenvatinib for priority review and approval for HCC

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Ebola vaccine approved in China

Fosun Pharma reports Chinese IND application for FCN-437c

CStone cleared to begin clinical trials of CS-1001 in China

China FDA accepts fruquintinib NDA for advanced colorectal cancer

Tagrisso approved in China for NSCLC

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

NMPA RSS

NMPA
RSS